AAAAAA

   
Results: 1-9 |
Results: 9
Is psychotherapy more effective when therapists disclose information aboutthemselves?
Authors: Barrett, MS Berman, JS
Citation: Ms. Barrett et Js. Berman, Is psychotherapy more effective when therapists disclose information aboutthemselves?, J CONS CLIN, 69(4), 2001, pp. 597-603
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
Authors: Denhardt, DT Noda, M O'Regan, AW Pavlin, D Berman, JS
Citation: Dt. Denhardt et al., Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival, J CLIN INV, 107(9), 2001, pp. 1055-1061
Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation
Authors: O'Regan, A Berman, JS
Citation: A. O'Regan et Js. Berman, Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation, INT J EXP P, 81(6), 2000, pp. 373-390
Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells
Authors: O'Regan, AW Hayden, JM Berman, JS
Citation: Aw. O'Regan et al., Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells, J LEUK BIOL, 68(4), 2000, pp. 495-502
Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks
Authors: O'Regan, AW Nan, GJ Chupp, GL Berman, JS
Citation: Aw. O'Regan et al., Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks, IMMUNOL TOD, 21(10), 2000, pp. 475-478
Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection
Authors: Nau, GJ Chupp, GL Emile, JF Jouanguy, E Berman, JS Casanova, JL Young, RA
Citation: Gj. Nau et al., Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection, AM J PATH, 157(1), 2000, pp. 37-42
The researcher's own therapy allegiances: A "wild card" in comparisons of treatment efficacy
Authors: Luborsky, L Diguer, L Seligman, DA Rosenthal, R Krause, ED Johnson, S Halperin, G Bishop, M Berman, JS Schweizer, E
Citation: L. Luborsky et al., The researcher's own therapy allegiances: A "wild card" in comparisons of treatment efficacy, CL PSYCH-SC, 6(1), 1999, pp. 95-106
Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro
Authors: O'Regan, AW Chupp, GL Lowry, JA Goetschkes, M Mulligan, N Berman, JS
Citation: Aw. O'Regan et al., Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro, J IMMUNOL, 162(2), 1999, pp. 1024-1031
Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin
Authors: Nau, GJ Liaw, L Chupp, GL Berman, JS Hogan, BLM Young, RA
Citation: Gj. Nau et al., Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin, INFEC IMMUN, 67(8), 1999, pp. 4223-4230
Risultati: 1-9 |